Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 122,758 shares at $3.57 ($438K) on 2025-07-09, disclosed to the SEC on 2025-07-10.
Open-market sale of $438k RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.57 | 18,639 | $67K | 15.2% |
| 2 | $3.57 | 18,639 | $67K | 15.2% |
| 3 | $3.57 | 42,740 | $153K | 34.8% |
| 4 | $3.57 | 42,740 | $153K | 34.8% |
| Total | $3.57 avg | 122,758 | $438K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |